CGClara García‐Mateos

Clara García‐Mateos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Clara García‐Mateos has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Antoni Riera

    Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, Barcelona 08028, Spain

    3 shared publications
  • Pep Rojo

    Institute of Research in Biomedicine (IRB Barcelona) The Barcelona Institute of Science and Technology (BIST) Baldiri Reixach 10 08028 Barcelona Spain

    3 shared publications
  • Xavier Verdaguer

    Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, Barcelona E-08028, Spain

    3 shared publications
  • Albert Cabré

    Institute of Research in Biomedicine (IRB Barcelona) The Barcelona Institute of Science and Technology (BIST) Baldiri Reixach 10 08028 Barcelona Spain

    2 shared publications
  • Medea Molinari

    Institute of Research in Biomedicine (IRB Barcelona) The Barcelona Institute of Science and Technology (BIST) Baldiri Reixach 10 08028 Barcelona Spain

    2 shared publications
  • Alpesh K. Sharma

    Department of Chemistry, Indian Institute of Technology Delhi, New Delhi 110016, India

    1 shared publication

Latest Publications

  • Open Access

    Base‐Promoted Homolytic Aromatic Substitution (BHAS) Reactions and Hydrodehalogenations Driven by Green Light and an Iron(III)‐NHC Photoredox Catalyst

    by Lisa H. M. de Groot, Clara García‐Mateos, Catherine E. Johnson, Valtýr Freyr Hlynsson, Alpesh K. Sharma, Reiner Lomoth, Kenneth Wärnmark

    An Fe(III)‐NHC complex has been employed for the green light driven catalysis of base‐promoted homolytic aromatic substitution (BHAS) reactions. Tributylamine was used as a sacrificial electron donor, together with potassium carbonate as base in dimethyl sulfoxide as solvent. In contrast to previously studied photocatalysts, the excited Fe(III)‐NHC complex is not reducing the arylhalide substrates. Instead, the latter are activated by α‐aminoalkyl radicals formed upon reductive quenching of the photocatalyst by tributylamine. Avoiding strongly reducing photocatalysts as well as strong base, these mild reaction conditions allowed for the expansion of the substrate scope to accommodate also aldehyde and ester substituents. 100 % conversion was obtained after 48 h of irradiation. In this way a wide variety of cyclized products and their corresponding hydrodehalogenated products were obtained as isolated and pure compounds, in the vast majority of cases.


  • Open Access

    Highly Enantioselective Synthesis of 3,3-Diarylpropyl Amines and 4-Aryl Tetrahydroquinolines via Ir-Catalyzed Asymmetric Hydrogenation

    by Martí Sidro, Clara García-Mateos, Pep Rojo, Yisong Wen, Antoni Riera, Xavier Verdaguer

    Chiral nitrogen-containing compounds are crucial for the chemical, pharmaceutical, and agrochemical industries. Nevertheless, the synthesis of certain valuable scaffolds remains underdeveloped due to the vast chemical space available. In this work, we present a diastereoselective methodology for synthesizing 3,3-diarylallyl phthalimides, which, following iridium-catalyzed asymmetric hydrogenation using Ir-UbaPHOX, yield 3,3-diarylpropyl amines with high enantioselectivity (98-99% ee). The importance of alkene purity to achieve high enantioselectivity is discussed. The synthetic utility of the chiral propylamines obtained is demonstrated through the preparation of medicinally useful bioactive compounds like the drugs tolterodine and tolpropamine and 4-aryl tetrahydroquinolines. This strategy enables the synthesis of these compounds with the highest enantioselectivity reported to date.


  • Open Access

    Iridium‐Catalyzed Asymmetric Hydrogenation of 2,3‐Diarylallyl Amines with a Threonine‐Derived P‐Stereogenic Ligand for the Synthesis of Tetrahydroquinolines and Tetrahydroisoquinolines

    by Pep Rojo, Medea Molinari, Albert Cabré, Clara García‐Mateos, Antoni Riera, Xavier Verdaguer

    Chiral compounds containing nitrogen heteroatoms are fundamental substances for the chemical, pharmaceutical and agrochemical industries. However, the preparation of some of these interesting scaffolds is still underdeveloped. Herein we present the synthesis of a family of P‐stereogenic phosphinooxazoline iridium catalysts from L‐threonine methyl ester and their use in the asymmetric hydrogenation of N‐Boc‐2,3‐diarylallyl amines, achieving very high enantioselectivity. Furthermore, the synthetic utility of the 2,3‐diarylpropyl amines obtained is demonstrated by their transformation to 3‐aryl‐tetrahydroquinolines and 4‐benzyl‐tetrahydroisoquinolines, which have not yet been obtained in an enantioselective manner by direct reduction of the corresponding aromatic heterocycles. This strategy allows the preparation of these types of alkaloids with the highest enantioselectivity reported up to date.


  • Open Access

    Iridium‐Catalyzed Asymmetric Hydrogenation of 2,3‐Diarylallyl Amines with a Threonine‐Derived P‐Stereogenic Ligand for the Synthesis of Tetrahydroquinolines and Tetrahydroisoquinolines

    by Pep Rojo, Medea Molinari, Albert Cabré, Clara García‐Mateos, Antoni Riera, Xavier Verdaguer

    Chiral compounds containing nitrogen heteroatoms are fundamental substances for the chemical, pharmaceutical and agrochemical industries. However, the preparation of some of these interesting scaffolds is still underdeveloped. Herein we present the synthesis of a family of P‐stereogenic phosphinooxazoline iridium catalysts from L‐threonine methyl ester and their use in the asymmetric hydrogenation of N‐Boc‐2,3‐diarylallyl amines, achieving very high enantioselectivity. Furthermore, the synthetic utility of the 2,3‐diarylpropyl amines obtained is demonstrated by their transformation to 3‐aryl‐tetrahydroquinolines and 4‐benzyl‐tetrahydroisoquinolines, which have not yet been obtained in an enantioselective manner by direct reduction of the corresponding aromatic heterocycles. This strategy allows the preparation of these types of alkaloids with the highest enantioselectivity reported up to date.